HRID1662622

反应详情

EQUATION

反应方程式

REACTANTS

反应物

结构：O=S(=O)(Cl)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F

HCID2736077

2,5-Bis(2,2,2-trifluoroethoxy)benzene-1-sulfonyl chloride

C10H7ClF6O4S

结构：COc1ccccc1C1(N2CCCC[C@H]2C(=O)N(C)C)C(=O)Nc2ccc(Cl)cc21

HCID67429052

未命名化合物

PRODUCTS

生成物

结构：COc1ccccc1C1(N2CCCC[C@H]2C(=O)N(C)C)C(=O)N(S(=O)(=O)c2cc(OCC(F)(F)F)ccc2OCC(F)(F)F)c2ccc(Cl)cc21

HCID59867899

未命名化合物

收率 66.6%

PROCEDURE

实验过程

With 200 mg of (2S)-1-[5-chloro-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-N,N-dimethylpiperidine-2-carboxamide, which is the compound described in Preparation 3.49 (Isomer B) of the brochure No. WO01/98295, and 183 mg of 2,5-bis(2,2,2-trifluoroethoxy)benzene sulfonyl chloride as starting materials, 238 mg of the title compound (colorless amorphous) was obtained by a similar method to Example 2.

WORKUP

后处理

customdescribed in Preparation 3.49 (Isomer B) of the brochure No

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-059cc39c6919452f9040f369017eb268
来源数据集: uspto-grants-2011_10
DOI: 10.6084/m9.figshare.5104873.v1
专利: US08030499B2
来源说明: uspto-grants-2011_10

反应 SMILES

[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6](=[O:11])[C:5]2([N:20]1[CH2:25][CH2:24][CH2:23][CH2:22][C@H:21]1[C:26]([N:28]([CH3:30])[CH3:29])=[O:27])[C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=1[O:18][CH3:19].[F:31][C:32]([F:52])([F:51])[CH2:33][O:34][C:35]1[CH:40]=[CH:39][C:38]([O:41][CH2:42][C:43]([F:46])([F:45])[F:44])=[CH:37][C:36]=1[S:47](Cl)(=[O:49])=[O:48]>>[F:52][C:32]([F:31])([F:51])[CH2:33][O:34][C:35]1[CH:40]=[CH:39][C:38]([O:41][CH2:42][C:43]([F:44])([F:45])[F:46])=[CH:37][C:36]=1[S:47]([N:7]1[C:8]2[C:4](=[CH:3][C:2]([Cl:1])=[CH:10][CH:9]=2)[C:5]([N:20]2[CH2:25][CH2:24][CH2:23][CH2:22][C@H:21]2[C:26]([N:28]([CH3:29])[CH3:30])=[O:27])([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=2[O:18][CH3:19])[C:6]1=[O:11])(=[O:49])=[O:48]